Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
about
Cell(s) of Origin of Langerhans Cell HistiocytosisLangerhans cell histiocytosis in children: from the bench to bedside for an updated therapy.Pediatric lymphomas and histiocytic disorders of childhoodDifferentiating skin-limited and multisystem Langerhans cell histiocytosis.Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature.How I treat Langerhans cell histiocytosis.Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?New insights into the molecular pathogenesis of langerhans cell histiocytosis.Updates on histiocytic disorders.Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment.Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck.Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.An unusual cause of proptosis.Salvage treatment of relapsed/refractory LCHAnakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester diseaseSystemic Rosai-Dorfman disease with central nervous system involvement.Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.Langerhans cell histiocytosis in children - a disease with many faces. Recent advances in pathogenesis, diagnostic examinations and treatment.
P2860
Q28087231-2074C7B6-D947-4D83-BFBF-6D1AEEA51493Q34515611-8FC0C576-9AE6-41D3-8C1A-289BB8696F64Q34605894-1A279A0E-E5F3-402B-9286-DB5E6502460CQ34624753-578AD4E1-1B41-4A10-AEA6-404EF39E32A3Q34886422-7118854C-25BB-463C-92A3-C418D00CBC47Q35820361-0021A8A0-F74C-4E60-8F21-E624316F2400Q36219698-5F7D560E-8CB8-49D6-A4C8-59F0FF03E956Q37540499-867C262E-974C-47C1-B934-570EF5F81CE4Q37589059-6F4367FB-FF8B-4067-AAE4-4678A468B9E7Q38194538-0628916C-32B3-4602-BA38-7BEDE8B759EFQ38259616-5DE54B58-19FA-46C1-9006-F343E6A9CC06Q38690183-12B07E5C-0767-458C-B5E0-B5EE3C74AC33Q38700671-10E1B177-8513-45BA-AD2C-422B5A14988DQ41837267-4EA621B0-1796-4256-95C7-BFFCE9924FF0Q42195584-0F110519-5C39-4F7F-AD16-B05745A65F85Q42386218-1560A2BF-BEEF-42A6-9474-6A64697AB608Q47780510-67D9CB9A-FAC8-41C3-B328-640713FC6EB6Q52714518-A9778E74-4C89-46FE-84DB-1A4718AF56B0Q55393516-B7675365-B359-49F9-92B5-A197FD32018F
P2860
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clofarabine salvage therapy in ...... oma and Rosai-Dorfman disease.
@ast
Clofarabine salvage therapy in ...... oma and Rosai-Dorfman disease.
@en
type
label
Clofarabine salvage therapy in ...... oma and Rosai-Dorfman disease.
@ast
Clofarabine salvage therapy in ...... oma and Rosai-Dorfman disease.
@en
prefLabel
Clofarabine salvage therapy in ...... oma and Rosai-Dorfman disease.
@ast
Clofarabine salvage therapy in ...... oma and Rosai-Dorfman disease.
@en
P2093
P2860
P356
P1476
Clofarabine salvage therapy in ...... loma and Rosai-Dorfman disease
@en
P2093
Carl E Allen
Don Coulter
Esperanza C Welsh
Francisco Rivera-Ortegón
Huy D Tran
Jeremy Jones
Linda Shaffer
Linda Stork
Lucie Turcotte
Lynda Kwon Beaupin
P2860
P304
P356
10.1002/PBC.24772
P577
2013-09-18T00:00:00Z